EXPLORING LONG TERNI HEALTH IMPLICATIONS IN FOUR ROTTERDAM PHENOTYPES OF POLYCYSTIC OVARY SYNDROME

被引:0
|
作者
Kaur, Raminder [1 ]
Kaur, Maninder [1 ]
Suri, Vanita [2 ]
机构
[1] Panjab Univ, Dept Anthropol, Chandigarh, India
[2] PGIMER, Dept Gynaecol & Obstet, Chandigarh, India
来源
ANTHROPOLOGIE-INTERNATIONAL JOURNAL OF HUMAN DIVERSITY AND EVOLUTION | 2024年 / 62卷 / 01期
关键词
Metabolic syndrome; PCOS women; PCOS phenotypes; BODY-MASS INDEX; INSULIN-RESISTANCE; METABOLIC SYNDROME; WOMEN; CONSENSUS; PREVALENCE; CRITERIA; SAMPLE; PCOS; RISK;
D O I
10.26720/anthro.23.11.09.1
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
Polycystic ovary syndrome is one of the escalating, but underdiagnosed hormonal disorder in women of reproductive age. The present study is an attempt to explore long term health implications in four Rotterdam the phenotypes of Polycystic ovary syndrome. For this purpose, a total of 223 PCOS women with age ranged from 18 to 45 years and living in the Chandigarh Capital Region were selected from the OPD, PGIMER, Chandigarh, (North India). Polycystic ovary syndrome among women were diagnosed as per the Rotterdam Criteria (2004). Findings of the study indicated that hirsutism (475%), acne (30.9%), seborrhoea (32.2%), menstrual irregularity (55.6%), and ovarian size >10 cm(3) (54.7%) were mostfrequently encounteredsymptoms in women having classic PCOS phenotype as compared to women with non-PCO PCOS, non-hyperandrogenic and ovulatory PCOS phenotype. The correspondence analysis depicted that classic PCOS phenotype were more closely and significantly associated with all the symptoms of PCOS with 83.6% variance, while ovulatory PCOS depicted least association with the symptoms of PCOS indicating that oligoanovulation play a vital role in the manifestation of symptoms related to PCOS. The classic PCOS phenotype showed higherprevalence of metabolic perturbations than otherphenotypes, thereby confirming classic PCOS phenotypes are at greater risk of long-term health consequences.
引用
收藏
页码:29 / 38
页数:10
相关论文
共 50 条
  • [21] Body Composition, Serum Concentrations of Androgens and Insulin Resistance in Different Polycystic Ovary Syndrome Phenotypes
    Polak, Aleksandra Maria
    Adamska, Agnieszka
    Krentowska, Anna
    Lebkowska, Agnieszka
    Hryniewicka, Justyna
    Adamski, Marcin
    Kowalska, Irina
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [22] Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria
    Avin S. Jamil
    Shahla K. Alalaf
    Namir G. Al-Tawil
    Talha Al-Shawaf
    Archives of Gynecology and Obstetrics, 2016, 293 : 447 - 456
  • [23] The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome
    Zhang, L.
    Fang, X.
    Li, L.
    Liu, R.
    Zhang, C.
    Liu, H.
    Tan, M.
    Yang, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2018, 41 (12): : 1401 - 1407
  • [24] Body Mass Index below Obesity Threshold Implies Similar Cardiovascular Risk among Various Polycystic Ovary Syndrome Phenotypes
    Bagir, Gulay Simsek
    Bakiner, Okan S.
    Bozkirli, Emre
    Cavlak, Gulhan
    Serinsoz, Hulya
    Ertorer, M. Eda
    MEDICAL PRINCIPLES AND PRACTICE, 2016, 25 (01) : 61 - 66
  • [25] Exploring heart rate variability in polycystic ovary syndrome: implications for cardiovascular health: a systematic review and meta-analysis
    Mirzohreh, Seyedeh Tarlan
    Panahi, Padideh
    Heidari, Fariba
    SYSTEMATIC REVIEWS, 2024, 13 (01)
  • [26] Psoriasis and polycystic ovary syndrome: a new link in different phenotypes
    Moro, Francesca
    Tropea, Anna
    Scarinci, Elisa
    Federico, Alex
    De Simone, Clara
    Caldarola, Giacomo
    Leoncini, Emanuele
    Boccia, Stefania
    Lanzone, Antonio
    Apa, Rosanna
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2015, 191 : 101 - 105
  • [27] Polycystic ovary syndrome and aging: Health implications after menopause
    Helvaci, Nafiye
    Yildiz, Bulent Okan
    MATURITAS, 2020, 139 : 12 - 19
  • [28] Anthropometric, Clinical and Biochemical Comparison of the Four Polycystic Ovarian Syndrome Phenotypes
    Sharami, Seyedeh Hajar
    Milani, Forozan
    Mohamadi, Fereshteh
    Pourmarzi, Davoud
    Kazemnejad, Ehsan
    Mollaee, Roghayeh
    KUWAIT MEDICAL JOURNAL, 2017, 49 (03): : 216 - 222
  • [29] Exploring new treatment options for polycystic ovary syndrome: Review of a novel antidiabetic agent SGLT2 inhibitor
    Marinkovic-Radosevic, Jelena
    Cigrovski Berkovic, Maja
    Kruezi, Egon
    Bilic-Curcic, Ines
    Mrzljak, Anna
    WORLD JOURNAL OF DIABETES, 2021, 12 (07) : 932 - 938
  • [30] Effects of distinct Polycystic Ovary Syndrome phenotypes on bone health
    Mills, Edouard G.
    Abbara, Ali
    Dhillo, Waljit S.
    Comninos, Alexander N.
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14